<DOC>
	<DOCNO>NCT01579487</DOCNO>
	<brief_summary>This study perform follow subject participate initial study ( ZA10-001 ) 2010 .</brief_summary>
	<brief_title>Extended Follow-Up Study Subjects Who Participated 2010 Study</brief_title>
	<detailed_description>The primary objective investigation ass durability treatment outcomes ZELTIQ System .</detailed_description>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>1 . Subject participate ZA10001 study , receive study treatment . 2 . Subject read sign write informed consent form . 1 . Subject surgical aesthetic procedure ( ) around abdomen since completion ZA10001 study treatment . 2 . Subject pregnant . 3 . Subject unable unwilling comply study requirement . 4 . Subject currently enrol clinical study unapproved investigational drug device . 5 . Any condition laboratory value would , professional opinion investigator , potentially affect integrity data .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Lipolysis</keyword>
	<keyword>Cryolipolysis</keyword>
	<keyword>Fat Reduction</keyword>
</DOC>